Participants

AVOCADO EXTRACT TO IMPROVE GLYCEMIA IN INDIVIDUALS WITH OBESITY (AVAIL Study)

In this study, we are investigating how an avocado extract affects blood glucose

You may be eligible to take part if you are:

  • Aged 45-65 years
  • Body mass index 30-40kg/m2
  • Waist circumference >94cm in men and >80cm in women

You will be required to attend our clinic lab at SAHMRI for ~4.5 hours on 2 occasions and visit SAHMRI monthly for 3 months.

You will be reimbursed for your time.

For more information contact: dietstudy@adelaide.edu.au.au including 'AVAIL' in the subject line or 8128 4860


EFFECTS OF AN EVENING PROTEIN PRELOAD ON BLOOD GLUCOSE, METABOLIC HEALTH AND GUT HORMONE RELEASE IN NIGHT SHIFT WORKERS

In this study, we are investigating how a protein supplement at dinner time may improve your blood glucose control overnight

You may be eligible to take part if you are:

  • Female
  • Aged 35-65 years
  • Overweight or obese
  • Work night shifts, either in a rotating, permanent or split shift schedule.

You will be required to attend our clinic at SAHMRI for a screening visit and on 3 separate occasions for ~ 4 hours. You will be reimbursed for your time.

For more information contact: dietstudy@adelaide.edu.au including 'SHIFT' in the subject line or call 8128 4862.


12 MONTH DIET TRIAL

In this study, we are comparing the effectiveness of two different diets to reduce the risk of chronic disease over 12 months. As part of the study, you will receive 5 telehealth consultations with an Accredited Practising Dietitian at no charge.

You may be eligible to take part if you:

  • Are aged 35 to 70 years
  • Have a BMI between 25 and 45 kg/m2
  • Do not currently have diabetes

You will need to attend our clinic at SAHMRI (North Terrace) on 7 occasions over 12 months (a total of ~7 hours). You will be reimbursed for your time. 

For more information contact: dietstudy@adelaide.edu.au including 'TREAD' in the subject line or call 8128 4862 to leave a message.


SWEET TASTE DIABETES CLINICAL TRIALS

Our aim is to investigate the way sugars enter the blood (from our food), and whether these uptake pathways in the gut can be targeted in new ways to better control blood sugar.

Our group has the following clinical studies underway, involving type 2 diabetic volunteers.

Study 1: Investigating a novel therapy to slow glucose entry into the blood, leading to improved control of blood glucose.

Study 2: Investigating whether diet supplementation with a combination of artificial sweeteners, affects blood glucose control.

You may be eligble to take part if you are:

  • Aged 28-75 years of age
  • Have Type 2 Diabetes, managed by diet or by metformin medication alone
  • Without Diabetes and healthy
  • Not under any dietary restrictions (you will be required to consume a beef lasagne meal)

To volunteer you must be willing to attend our clinic at SAHMRI and the Royal Adelaide Hospital on 3 separate occasions, over one month.

Upon successful completion of the study, volunteers will receive a $150 gift voucher. This research is approved by the Royal Adelaide Hospital Ethics Committee.

If you’d like to be involved in our research studies, it’s as simple as phoning or emailing us to register your interest.

Contact us on 8128 4863 or email sweetener@adelaide.edu.au


CSIRO is seeking volunteers for a number of research trials. Further information about current trials and how you can participate can be found here.

Get in touch
+61 8 8128 4000 info@sahmri.com
You can't miss us!
North Terrace Adelaide 5000 South Australia
Postal Address
PO BOX 11060 Adelaide 5001 South Australia
Key Partners
SAHMRI is located on the traditional lands of the Kaurna Nation.

The SAHMRI community acknowledges and respects the traditional owners, the family clans who are the Kaurna Nation from the Adelaide Plains region of South Australia. We acknowledge the clans of the Kaurna Nation and the sacred knowledge they hold for their country. We pay our respects to the Kaurna Nation, their ancestors and the descendants of these living family clans today.